Valneva SE (VALN)
NASDAQ
$6.17−$0.0550 (−0.88%) on the dayAs of the close; data may be delayed.
VALN price, last 12 months
Key stats
- Previous close
- $6.22
- Open
- $6.16
- Day range
- $6.08 – $6.19
- 52-week range
- $4.75 – $12.23
- Volume
- 12.5K
- Avg volume (20 days)
- 31.8K
- Market cap
- $582.2M
Performance
1W−6.0%
1M−7.9%
3M+18.8%
6M−2.5%
YTD−30.1%
1Y−40.2%
vs S&P 500, 1Y−56.9 pts
Technicals and fundamentals
About Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
- Listed on
- NASDAQ
- Market cap
- $582.2M